Sjs Investment Consulting Inc. Day One Biopharmaceuticals, Inc. Transaction History
Sjs Investment Consulting Inc.
- $679 Million
- Q4 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 20 shares of DAWN stock, worth $176. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20Holding current value
$176% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DAWN
# of Institutions
178Shares Held
71MCall Options Held
42.8KPut Options Held
60.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$56.6 Million10.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$54.4 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4.71MShares$41.4 Million0.62% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$39.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.48MShares$30.6 Million0.01% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $646M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...